Bloomage Biotechnology Corporation (688363) Stock Price, Fundamentals & Analysis

What 688363 does

Bloomage Biotechnology Corporation (688363) is a stock listed on the Shanghai Stock Exchange in the Basic Materials sector, under the Specialty Chemicals industry. The company is headquartered in Jinan, China, and employs 3,656 people. It researches, develops, produces, and sells bioactive materials, including a range of beauty and care products based on hyaluronic acid, marine DNA, and other bioactive ingredients.

Key numbers explained

• The current price is 34.7 CNY, down 1% today.
• The trailing P/E ratio of 73.8 compares the price to the last 12 months of earnings per share, which was 0.47 CNY.
• The forward P/E ratio of 39.6 uses expected future earnings, often seen as a gauge of growth expectations.
• The dividend yield is 0.55%, meaning the annual dividend represents roughly 0.55% of the current price, with 23% of earnings paid out as dividends.
• The ex-dividend date is Jul 13, 2026; buyers on or after that date do not receive the next dividend.
• The beta of 0.43 suggests the stock has historically been less volatile than the broader market.
• The 52-week range is 32.92 – 56.76, and the price is down 36.9% over the past year.
• The debt-to-equity ratio of 6.8% indicates a low level of debt relative to shareholder equity.

What to watch

Bloomage Biotechnology Corporation operates in the bioactive materials space, where demand can shift with trends in cosmetics and personal care. Investors often track revenue growth, which has declined 21.6% year over year to 3.69 mld. CNY, alongside margins such as the 6.1% profit margin and 3% operating margin. The stock is part of the Shanghai Stock Exchange ecosystem, which includes peers like Anhui Conch Cement (600585) and CHINA JUSHI (600176). Broader market movements, raw material costs, and regulatory changes in the cosmetics and chemicals sectors are general factors that can affect such stocks.